Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results

Title
Phase I Clinical Trial of Marizomib (NPI-0052) in Patients with Advanced Malignancies Including Multiple Myeloma: Study NPI-0052-102 Final Results
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 22, Issue 18, Pages 4559-4566
Publisher
American Association for Cancer Research (AACR)
Online
2016-04-27
DOI
10.1158/1078-0432.ccr-15-2616

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now